IP Infusion
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$2.0m | Series B | ||
$14.7m | Series C | ||
N/A | $50.0m Valuation: $50.0m | Acquisition | |
Total Funding | €15.2m |
Recent News about IP Infusion
EditIP Infusion is a market leader in providing open network operating systems, primarily serving telecommunications companies, data centers, and enterprise networks. The company operates in the networking industry, focusing on software solutions that enable interoperability and scalability across various hardware platforms. IP Infusion's core product, OcNOS, is a disaggregated network operating system designed to run on low-cost commodity hardware, making it a cost-effective alternative to traditional, hardware-centric networking solutions. The business model revolves around licensing its software to clients, offering both subscription-based and perpetual licensing options. Revenue is generated through software sales, support services, and professional consulting. IP Infusion's solutions are recognized for their maturity, completeness, and field-tested reliability, making them a preferred choice for clients looking to modernize and optimize their network infrastructures.
Keywords: open networking, network operating systems, OcNOS, telecommunications, data centers, enterprise networks, disaggregated systems, scalability, cost-effective, interoperability.